Article
A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors.
American journal of human genetics - 1 Oct 2005
Duan Qing Ling, Nikpoor Borzoo, Dube Marie-Pierre, Molinaro Giuseppe, Meijer Inge A, Dion Patrick, Rochefort Daniel, Saint-Onge Judith, Flury Leah, Brown Nancy J, Gainer James V, Rouleau Jean L, Agostoni Angelo, Cugno Massimo, Simon Pierre, Clavel Pierre, Potier Jacky, Wehbe Bassem, Benarbia Seddik, Marc-Aurele Julien, Chanard Jacques, Foroud Tatiana, Adam Albert, Rouleau Guy A
Abstract excerpt
Angiotensin I-converting enzyme inhibitors (ACEi), which are used to treat common cardiovascular diseases, are associated with a potentially life-threatening adverse reaction known as angioedema (AE-ACEi). We have previously documented a significant association between AE-ACEi and low plasma aminopeptidase P (APP) activity. With eight large pedigrees, we hereby demonstrate that this quantitative trait is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
